Doravirine, Lamivudine, and Tenofovir Disoproxil
DELSTRIGO
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
NADAC/unit
$92.9143
No Shortage
Tier 1: 17.9%
vs. brand DELSTRIGO: Generic saves up to -829% per unit
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.